Randall C. Schatzman, Chief Executive Officer at Bolt Biotherapeutics, Inc. (BOLT), bought 1,500 shares at $20.00 ($30K) on 2021-02-09, disclosed to the SEC on 2021-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |
| ALDR | SELL | 2016-08-03 | $622K | — | Filing → |